1. Cost-benefit analysis of serological and nucleic acid testing for hepatitis B virus in blood donors in southern China
- Author
-
Xianlin Ye, Wen Xiong, Xiaoxuan Xu, Jinfeng Zeng, He Xie, Bin Li, Baoren He, Limin Chen, and Qiuhong Mo
- Subjects
Blood screening ,Hepatitis B ,Cost-effectiveness analysis ,Nuleic acid testing ,Mini pool ,Individual donation ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Most Chinese blood centers have implemented mini pool (MP) HBV nucleic acid testing (NAT) together with HBsAg ELISA in routine blood donor screening for HBV infection since 2015, and a few centers upgraded MP to individual donation (ID) NAT screening recently, raising urgent need for cost-benefit analysis of different screening strategies. In an effort to prevent transfusion-transmitted infections (TTIs) for HBV, cost-benefit analyses of three different screening strategies: HBsAg alone, HBsAg plus MP NAT and HBsAg plus ID NAT were performed in blood donors from southern China where HBV infection was endemic. Methods MP-6 HBV NAT and ID NAT were adopted in parallel to screen blood donors for further comparative analysis. On the basis of screening data and the documented parameters, the number of window period (WP) infection, HBV acute infection, chronic hepatitis B infection (CHB) and occult hepatitis B infection (OBI) was evaluated, and the potential prevented HBV TTIs and benefits of these three strategies were predicted based on cost-benefit analysis by an estimation model. Results Of 132,323 donations, the yield rate for HBsAg-/DNA + screened by ID NAT (0.12%) was significantly higher than that by MP NAT (0.058%, P
- Published
- 2024
- Full Text
- View/download PDF